- Active Ingredients
Product Documentation
-
View RMM (Deferasirox Important information for patients about your treatment and possible side effects)
Last updated on this site: 30 Dec 2022
Reason for change: to update the hyperlink to SmPC from eMC to APS website.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintDeferasirox Accord 360 mg film-coated tablets
- PL Number:
- EU/1/19/1412/009-013
- MA Holder:
- Accord Healthcare S.L.U
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Patient Information Leaflet (PIL - Deferasirox Accord 90mg, 180mg, 360mg film-coated tablets)
Last updated on this site: 14 Jul 2023
Initial upload
View Summary of Product Characteristics (SmPC - Deferasirox Accord 90mg, 180mg, 360mg mg film-coated tablets)Last updated on this site: 14 Jul 2023
initial upload
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.